Literature DB >> 31682642

NAFLD: a multisystem disease that requires a multidisciplinary approach.

Christopher J Danford1, Michelle Lai1.   

Abstract

Entities:  

Keywords:  non-alcoholic steatohepatitis

Year:  2019        PMID： 31682642      PMCID： PMC6788273          DOI： 10.1136/flgastro-2019-101235

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  6 in total

1.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Paul Angulo; David E Kleiner; Sanne Dam-Larsen; Leon A Adams; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Jill C Keach; Heather D Lafferty; Alisha Stahler; Svanhildur Haflidadottir; Flemming Bendtsen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

Review 2.  Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Larissa L Fujii; Mohammad Hassan Murad; Zhen Wang; Sumeet K Asrani; Richard L Ehman; Patrick S Kamath; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

3.  Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH.

Authors:  Eduardo Vilar-Gomez; Luis Calzadilla-Bertot; Scott L Friedman; Bienvenido Gra-Oramas; Licet Gonzalez-Fabian; Sacha Lazo-Del Vallin; Moises Diago; Leon A Adams
Journal:  Liver Int       Date:  2017-06-14       Impact factor: 5.828

4.  Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.

Authors:  Jacqueline A Bachofner; Piero V Valli; Arne Kröger; Irina Bergamin; Patrizia Künzler; Adriana Baserga; Dominique Braun; Burkhardt Seifert; Anja Moncsek; Jan Fehr; David Semela; Lorenzo Magenta; Beat Müllhaupt; Benedetta Terziroli Beretta-Piccoli; Joachim C Mertens
Journal:  Liver Int       Date:  2016-11-03       Impact factor: 5.828

5.  Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.

Authors:  Uchenna Anyanwagu; Jil Mamza; Rajnikant Mehta; Richard Donnelly; Iskandar Idris
Journal:  Heart       Date:  2016-05-23       Impact factor: 5.994

6.  Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial.

Authors:  R C Andrews; A R Cooper; A A Montgomery; A J Norcross; T J Peters; D J Sharp; N Jackson; K Fitzsimons; J Bright; K Coulman; C Y England; J Gorton; A McLenaghan; E Paxton; A Polet; C Thompson; C M Dayan
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321
  6 in total
  7 in total

1.  Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Authors:  Lanfeng Xue; Zhiliang Deng; Wenhui Luo; Xingxiang He; Yu Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

2.  Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease.

Authors:  Guangyu Jiang; Dayin Chen; Wenpeng Li; Chengcheng Liu; Jiguang Liu; Yingxue Guo
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

Review 3.  Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases.

Authors:  Maite Martínez-Uña; Yaiza López-Mancheño; Carlos Diéguez; Manuel A Fernández-Rojo; Marta G Novelle
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

4.  Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway.

Authors:  Yi Wang; Bingbing Liu; Peixuan Wu; Yi Chu; Sisi Gui; Yazhen Zheng; Xiaodong Chen
Journal:  Antioxidants (Basel)       Date:  2022-02-10

5.  Network Pharmacology-Based Analysis of Pogostemon cablin (Blanco) Benth Beneficial Effects to Alleviate Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Yizhe Cui; Qiuju Wang; Renxu Chang; Ahmad Aboragah; Juan J Loor; Chuang Xu
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

Review 6.  Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications.

Authors:  Doris Ogresta; Anna Mrzljak; Maja Cigrovski Berkovic; Ines Bilic-Curcic; Sanja Stojsavljevic-Shapeski; Lucija Virovic-Jukic
Journal:  J Clin Transl Hepatol       Date:  2022-01-12

7.  Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment.

Authors:  Patrice Lazure; Jeremy W Tomlinson; Kris V Kowdley; Paolo Magni; Raul D Santos; Ginny Jacobs; Suzanne Murray
Journal:  Liver Int       Date:  2022-06-09       Impact factor: 8.754
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.